Quest Diagnostics - Press Releases

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996

Quest Diagnostics to Speak at the Jefferies Global Healthcare Conference

06/02/23

Quest Diagnostics to Speak at the William Blair 43rd Annual Growth Stock Conference

06/01/23

Post-Accident Workforce Drug Positivity for Marijuana Reached 25-Year High in 2022, Quest Diagnostics Drug Testing Index Analysis Finds

05/18/23

Quest Diagnostics Elects Luis A. Diaz, Jr., M.D. to its Board, Expanding the Number of Directors to 10

05/17/23

Quest Diagnostics Declares Quarterly Cash Dividend

05/16/23

Quest Diagnostics Extends Alzheimer's Disease Portfolio with New AI-Powered Test Service from uMETHOD Health

05/04/23

Quest Diagnostics Reports First Quarter 2023 Financial Results; Updates Guidance for Full Year 2023

04/27/23

Quest Diagnostics to Acquire Haystack Oncology, Adding Sensitive Liquid Biopsy Technology for Improving Personalized Cancer Care to Oncology Portfolio

04/27/23

Quest Diagnostics and NewYork-Presbyterian Complete Laboratory Services Acquisition

04/17/23

Quest Diagnostics to Release First Quarter 2023 Financial Results on April 27, 2023

04/04/23

Quest Diagnostics Unveils Advanced Transplant Diagnostic Services Featuring Anywhere-Access in the United States

03/22/23

First-of-Its-Kind Post-COVID-19 Panels Available at questhealth.com

03/21/23

Quest Diagnostics Completes Acquisition of Northern Light Laboratory in Maine

03/20/23

Quest Diagnostics to Discuss Strategic Priorities to Drive Growth and Create Shareholder Value at 2023 Investor Day

03/16/23

Quest Diagnostics Board of Directors Elects James E. Davis Chairman of the Board

03/03/23

Quest Diagnostics Teams Up with Tower Health to Deliver High-Value, Innovative Laboratory Services

02/16/23

Quest Diagnostics and NewYork-Presbyterian Agree to Laboratory Services Transaction

02/14/23

Quest Diagnostics to Host Investor Day on March 16, 2023

02/13/23

QUEST DIAGNOSTICS REPORTS FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS; PROVIDES GUIDANCE FOR FULL YEAR 2023

02/02/23

Quest Diagnostics Increases Dividend 7.6% To $0.71 Per Quarter; Announces $1 Billion Increase in Share Repurchase Authorization

02/02/23

FORTUNE Magazine Names Quest Diagnostics one of 2023 "World's Most Admired Companies" for Ninth Consecutive Year

02/01/23

More Americans Know Their Horoscope Sign Than Their Blood Type, Survey Reveals

01/23/23

Quest Diagnostics to Release Fourth Quarter and Full Year 2022 Financial Results on February 2, 2023

01/20/23

Pack Health to Expand in Birmingham to Accelerate Growth of Health Coaching Services Nationwide

01/17/23

Quest Diagnostics to Speak at the 41st Annual J.P. Morgan Healthcare Conference

01/04/23